8% Fixed Promissory Note Sample Contracts

AMENDMENT No. 1 To 8% FIXED PROMISSORY NOTE
8% Fixed Promissory Note • October 14th, 2020 • RespireRx Pharmaceuticals Inc. • Pharmaceutical preparations • Delaware
Contract Type
Filed
October 14th, 2020
Company
Industry
Jurisdiction
This Amendment No. 1 to 8% Fixed Promissory Note (this “Amendment”) is dated September 30, 2020 (the “Effective Date”), and is made by and among RespireRx Pharmaceuticals Inc., a Delaware corporation (the “Company”) and White Lion Capital LLC, a Nevada limited liability company (the “Investor”).

8% FIXED PROMISSORY NOTE
8% Fixed Promissory Note • December 14th, 2021 • RespireRx Pharmaceuticals Inc. • Pharmaceutical preparations • Delaware
Contract Type
Filed
December 14th, 2021
Company
Industry
Jurisdiction
This Amendment No. 3 to 8% Fixed Promissory Note (this “Amendment”), effective as of December 1, 2021 (the “Effective Date”), is made by and among RespireRx Pharmaceuticals Inc., a Delaware corporation (the “Company”) and White Lion Capital LLC, a Nevada limited liability company (the “Investor”).

8% FIXED PROMISSORY NOTE
8% Fixed Promissory Note • July 30th, 2021 • RespireRx Pharmaceuticals Inc. • Pharmaceutical preparations • Delaware
Contract Type
Filed
July 30th, 2021
Company
Industry
Jurisdiction
This Amendment No. 2 to 8% Fixed Promissory Note (this “Amendment”), effective as of July 27, 2021 (the “Effective Date”), is made by and among RespireRx Pharmaceuticals Inc., a Delaware corporation (the “Company”) and White Lion Capital LLC, a Nevada limited liability company (the “Investor”).